Literature DB >> 20306013

Incidence of hospitalised schizophrenia in Finland since 1980: decreasing and increasing again.

Raimo K R Salokangas1, Mika Helminen, Anna-Maija Koivisto, Helena Rantanen, Hannu Oja, Sami Pirkola, Kristian Wahlbeck, Matti Joukamaa.   

Abstract

BACKGROUND: It is suggested that the incidence of schizophrenia is decreasing. However, changes in the number of psychiatric beds available and diagnostic practice have not always been taken into account. We studied the annual first-admission rate (per 100,000) for schizophrenia (FARsch) during a rapid deinstitutionalisation period in Finland.
METHOD: From the National Finnish Hospital discharge register, we identified all 30,041, 15- to 64-year-old patients admitted for the first time with schizophrenia to hospitals in Finland between 1980 and 2003.
RESULTS: FARsch decreased from 56.39 in 1980 to 29.51 in 1991 and slightly increased thereafter. Changes in FARsch corresponded with changes in all admissions. FARsch was higher when using ICD-8, but lower when DSM-IIIR and ICD-10 were used.
CONCLUSION: Changes in the number of psychiatric beds available, admission policy and diagnostic practice may explain the majority of variations in FARsch. Possibly, increased use of illegal drugs and improved treatment of depression are reflected in the increase in FARsch.

Entities:  

Mesh:

Year:  2010        PMID: 20306013     DOI: 10.1007/s00127-010-0209-z

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  30 in total

Review 1.  Incidence of schizophrenia does not vary with economic status of the country: evidence from a systematic review.

Authors:  Sukanta Saha; Joy Welham; David Chant; John McGrath
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-03-06       Impact factor: 4.328

2.  Declining perinatal mortality in Finland between 1987 and 1994: contribution of different subgroups.

Authors:  E Forssas; M Gissler; E Hemminki
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1998-10       Impact factor: 2.435

3.  The effect of gender in diagnosing early schizophrenia--an experimental case simulation study.

Authors:  Anne Høye; Grigory Rezvy; Vidje Hansen; Reidun Olstad
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-05-13       Impact factor: 4.328

4.  The Finnish National Schizophrenia Project 1981-1987: 10-year evaluation of its results.

Authors:  T Tuori; V Lehtinen; A Hakkarainen; J Jääskeläinen; A Kokkola; M Ojanen; K Pylkkänen; R Salokangas; J Solantaus; Y Alanen
Journal:  Acta Psychiatr Scand       Date:  1998-01       Impact factor: 6.392

5.  Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization.

Authors:  Helena Rantanen; Anna-Maija Koivisto; Raimo K R Salokangas; Mika Helminen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-28       Impact factor: 4.328

6.  First-contact rate for schizophrenia in community psychiatric care. Consideration of the oestrogen hypothesis.

Authors:  R K Salokangas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

7.  Time trends in the care-based incidence of schizophrenia.

Authors:  A J Oldehinkel; R Giel
Journal:  Br J Psychiatry       Date:  1995-12       Impact factor: 9.319

8.  Decreasing rates of incident schizophrenia cases in psychiatric service: A review of the literature.

Authors:  P Munk-Jørgensen
Journal:  Eur Psychiatry       Date:  1995       Impact factor: 5.361

9.  Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales.

Authors:  Matthew Hickman; Peter Vickerman; John Macleod; James Kirkbride; Peter B Jones
Journal:  Addiction       Date:  2007-04       Impact factor: 6.526

10.  Sex differences in the risk of schizophrenia: evidence from meta-analysis.

Authors:  Andre Aleman; René S Kahn; Jean-Paul Selten
Journal:  Arch Gen Psychiatry       Date:  2003-06
View more
  6 in total

1.  Treatment prevalence and incidence of schizophrenia in Quebec using a population health services perspective: different algorithms, different estimates.

Authors:  Alain Vanasse; Josiane Courteau; Marie-Josée Fleury; Jean-Pierre Grégoire; Alain Lesage; Jocelyne Moisan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-29       Impact factor: 4.328

2.  Late new morbidity in survivors of adolescent and young-adulthood brain tumors in Finland: a registry-based study.

Authors:  Mirja Erika Gunn; Nea Malila; Tuire Lähdesmäki; Mikko Arola; Marika Grönroos; Jaakko Matomäki; Päivi Maria Lähteenmäki
Journal:  Neuro Oncol       Date:  2015-07-01       Impact factor: 12.300

3.  Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort.

Authors:  Ulrich Reininghaus; Rina Dutta; Paola Dazzan; Gillian A Doody; Paul Fearon; Julia Lappin; Margaret Heslin; Adanna Onyejiaka; Kim Donoghue; Ben Lomas; James B Kirkbride; Robin M Murray; Tim Croudace; Craig Morgan; Peter B Jones
Journal:  Schizophr Bull       Date:  2014-09-27       Impact factor: 9.306

Review 4.  Social inequality, scientific inequality, and the future of mental illness.

Authors:  Charles E Dean
Journal:  Philos Ethics Humanit Med       Date:  2017-12-19       Impact factor: 2.464

5.  Annual Prevalence and Incidence of Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A National Health Insurance Data-Based Study.

Authors:  Sung Joon Cho; Jungmee Kim; Yeon Ju Kang; Seung Yeon Lee; Hwo Yeon Seo; Jee Eun Park; Haebin Kim; Kyoung-Nam Kim; Jin Yong Lee; Jee Hoon Sohn
Journal:  Psychiatry Investig       Date:  2020-01-25       Impact factor: 2.505

6.  A comparison of the cumulative incidence and early risk factors for psychotic disorder in young adults in the Northern Finland Birth Cohorts 1966 and 1986.

Authors:  S Filatova; R Marttila; H Koivumaa-Honkanen; T Nordström; J Veijola; P Mäki; G M Khandaker; M Isohanni; E Jääskeläinen; K Moilanen; J Miettunen
Journal:  Epidemiol Psychiatr Sci       Date:  2016-03-28       Impact factor: 6.892

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.